Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Juno Therapeutics, Inc., A Bristol-myers Squibb Company

Clinical trials sponsored by Juno Therapeutics, Inc., A Bristol-myers Squibb Company, explained in plain language.

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 1

Engineered immune cells take on rare blood disorders

Disease control Not yet recruiting

This phase 2 trial tests a personalized CAR T cell therapy called zolacabtagene autoleucel in 52 adults with chronic immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA). The treatment uses the patient's own immune cells, modified to target and destroy faulty B cel…

Phase: PHASE2 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC